Sofgen Pharma SA
OTC:PROCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sofgen Pharma SA
OTC:PROCF
|
LU |
|
G
|
Gritstone bio Inc
F:2JQ
|
US |
|
Transition SA
PAR:TRAN
|
FR |
|
S
|
Scope Industries Bhd
KLSE:SCOPE
|
MY |
|
Canyon Creek Food Company Ltd
XTSX:CYF
|
CA |
|
Enertime SAS
F:E0T
|
FR |
|
United Health Products Inc
OTC:UEEC
|
US |
|
B
|
BIG Camera Corporation PCL
SET:BIG
|
TH |
|
Eureka Group Holdings Ltd
F:UM7
|
AU |
|
T
|
TPC Consolidated Ltd
XBER:T7P
|
AU |
|
Engineer Gold Mines Ltd
XTSX:EAU
|
CA |
Bankruptcy Probability
Sofgen Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Dec 31, 2023 | 23.8m |
| Sep 30, 2023 | 25.8m |
| Jun 30, 2023 | 19.9m |
| Mar 31, 2023 | 23m |
| Dec 31, 2023 | 4.2m |
| Sep 30, 2023 | 6.2m |
| Jun 30, 2023 | 8.2m |
| Mar 31, 2023 | 1.9m |
| Dec 31, 2023 | 31.1m |
| Sep 30, 2023 | 220.7m |
| Jun 30, 2023 | 170m |
| Mar 31, 2023 | 150m |
Solvency Ratios
Solvency Ratios Comparison
Sofgen Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LU |
|
Sofgen Pharma SA
OTC:PROCF
|
698.2k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
627B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
335.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
177.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
263.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sofgen Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sofgen Pharma SA has total debt of 31.1m USD. This includes both short-term (0 USD) and long-term (31.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
